Insufficient scRNA-seq data for expression of OPLAH at single-cell level.
Insufficient scRNA-seq data for expression of OPLAH at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 3482.84 | 226 / 226 | 98% | 42.79 | 398 / 406 |
prostate | 99% | 1944.30 | 243 / 245 | 98% | 26.54 | 493 / 502 |
esophagus | 98% | 1946.71 | 1422 / 1445 | 98% | 30.32 | 180 / 183 |
intestine | 99% | 2426.69 | 958 / 966 | 97% | 32.06 | 512 / 527 |
kidney | 100% | 2780.89 | 89 / 89 | 94% | 20.64 | 848 / 901 |
stomach | 99% | 2924.96 | 354 / 359 | 95% | 35.41 | 271 / 286 |
lung | 97% | 1428.94 | 560 / 578 | 95% | 23.49 | 1094 / 1155 |
breast | 99% | 1844.93 | 453 / 459 | 91% | 20.86 | 1012 / 1118 |
ovary | 93% | 1178.21 | 168 / 180 | 95% | 30.09 | 408 / 430 |
pancreas | 98% | 1145.70 | 322 / 328 | 89% | 15.28 | 159 / 178 |
bladder | 90% | 950.86 | 19 / 21 | 87% | 19.82 | 440 / 504 |
uterus | 75% | 687.84 | 127 / 170 | 85% | 16.75 | 391 / 459 |
thymus | 98% | 1318.00 | 642 / 653 | 49% | 4.89 | 294 / 605 |
adrenal gland | 100% | 2865.17 | 258 / 258 | 40% | 6.49 | 91 / 230 |
skin | 95% | 1870.56 | 1724 / 1809 | 41% | 7.62 | 192 / 472 |
brain | 85% | 916.56 | 2256 / 2642 | 42% | 4.99 | 296 / 705 |
eye | 0% | 0 | 0 / 0 | 100% | 44.85 | 80 / 80 |
muscle | 100% | 3838.00 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1885.95 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 98% | 1649.62 | 1181 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 20.65 | 44 / 45 |
heart | 95% | 4726.78 | 819 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 69% | 2271.83 | 638 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 59% | 9.84 | 17 / 29 |
blood vessel | 18% | 151.73 | 245 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006749 | Biological process | glutathione metabolic process |
GO_0005829 | Cellular component | cytosol |
GO_0017168 | Molecular function | 5-oxoprolinase (ATP-hydrolyzing) activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
GO_0005524 | Molecular function | ATP binding |
Gene name | OPLAH |
Protein name | 5-oxoprolinase, ATP-hydrolysing 5-oxoprolinase (ATP-hydrolysing) 5-oxoprolinase (EC 3.5.2.9) (5-oxo-L-prolinase) (5-OPase) (Pyroglutamase) |
Synonyms | |
Description | FUNCTION: Catalyzes the cleavage of 5-oxo-L-proline to form L-glutamate coupled to the hydrolysis of ATP to ADP and inorganic phosphate. . |
Accessions | ENST00000567871.2 A7E261 O14841 A0A087WY99 ENST00000618853.5 |